Fierce Biotech

Big Pharma-backed Nuvig halts development of lead fusion protein in rare autoimmune disease

Big Pharma-backed Nuvig Therapeutics has halted one of two trials for its sole clinical asset after determining the program ...
Fierce Biotech

Kairos seizes moment to push prostate cancer prospect into earlier setting

Kairos Pharma is moving prostate cancer prospect ENV-105 into an earlier line of treatment in response to midphase survival ...
Fierce Biotech

Abbott nabs FDA approval for new CardioMEMS HF System that allows heart readings to be seen at home

Abbott has been given U.S. clearance for new updates to its CardioMEMS HF System that allow for patient-facing capabilities ...
Fierce Biotech

ArriVent’s phase 3 lung cancer trial flops, sinking stock

A phase 3 lung cancer study of ArriVent BioPharma’s EGFR inhibitor has missed its primary endpoint, sending the biotech’s stock down 57% in early trading.
Fierce Biotech

Biotech’s peptide shows promise as ‘bait molecule’ to treat neuropathic pain in mice

Using a short lapidated peptide (SLiP) developed by Mimetic Medicines disrupted a crucial voltage-gated sodium channel ...